Overview

To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China

Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
Observe the effects of HSK16149 capsule combined with acetyl-L-carnitine hydrochloride tablets and lipoic acid combined with acetyl-L-carnitine hydrochloride tablets Efficacy and safety in diabetic peripheral neuralgia patients in China
Phase:
N/A
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd.